Maurizio Martelli | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Digital droplet PCR as a predictive tool for successful discontinuation outcome in chronic myeloid leukemia: Is it time to introduce it in the clinical practice?	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2020
Early Palliative Home Care versus Hospital Care for Patients with Hematologic Malignancies: A Cost-Effectiveness Study	JOURNAL OF PALLIATIVE MEDICINE	2020
Relapsed/refractory diffuse large B-cell lymphoma patients. A multicenter retrospective analysis of eligibility criteria for car-T cell therapy	LEUKEMIA & LYMPHOMA	2020
Predictive factors for response and survival in elderly acute myeloid leukemia patients treated with hypomethylating agents: a real-life experience	ANNALS OF HEMATOLOGY	2020
The advantages and risks of ruxolitinib for the treatment of polycythemia vera	EXPERT REVIEW OF HEMATOLOGY	2020
Switch from branded to generic imatinib: impact on molecular responses and safety in chronic-phase chronic myeloid leukemia patients	ANNALS OF HEMATOLOGY	2020
Baseline PET features to predict prognosis in primary mediastinal B cell lymphoma: a comparative analysis of different methods for measuring baseline metabolic tumour volume.	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING	2019
Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL.	BLOOD	2019
Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma	BRITISH JOURNAL OF HAEMATOLOGY	2019
Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Patients: A Retrospective Analysis of Eligibility Criteria for CAR-T Cell Therapy	BLOOD	2019
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding	HEMATOLOGICAL ONCOLOGY	2018
Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma	BLOOD	2018
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death	BRITISH JOURNAL OF HAEMATOLOGY	2018
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS	2017
Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi	THE LANCET. HAEMATOLOGY	2017
Primary mediastinal large B-cell lymphoma	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2017
Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy. results from a monoinstitutional cohort analysis of long-term survivors	HEMATOLOGICAL ONCOLOGY	2017
Cytological diagnostic features of late breast implant seromas. From reactive to anaplastic large cell lymphoma	PLOS ONE	2017
In Reply to Adams and Kwee	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS	2017
Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: Improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy	JOURNAL OF CLINICAL ONCOLOGY	2017